Year |
Citation |
Score |
2009 |
Hegde ML, Bharathi P, Suram A, Venugopal C, Jagannathan R, Poddar P, Srinivas P, Sambamurti K, Rao KJ, Scancar J, Messori L, Zecca L, Zatta P. Challenges associated with metal chelation therapy in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 17: 457-68. PMID 19363258 DOI: 10.3233/Jad-2009-1068 |
0.563 |
|
2008 |
Venugopal C, Demos CM, Rao KS, Pappolla MA, Sambamurti K. Beta-secretase: structure, function, and evolution. Cns & Neurological Disorders Drug Targets. 7: 278-94. PMID 18673212 DOI: 10.2174/187152708784936626 |
0.646 |
|
2008 |
Zhou Y, Suram A, Venugopal C, Prakasam A, Lin S, Su Y, Li B, Paul SM, Sambamurti K. Geranylgeranyl pyrophosphate stimulates gamma-secretase to increase the generation of Abeta and APP-CTFgamma. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 47-54. PMID 17666454 DOI: 10.1096/Fj.07-8175Com |
0.636 |
|
2008 |
Sambamurti K, Prakasam A, Jayachandran AD, Venugopal C, Rao JK, Lahiri DK, Greig NH, Pappolla MA, Zhou Y. P1-412: Isoprenoids phenocopy familial Alzheimer's disease mutations and regulate gamma-secretase Alzheimer's & Dementia. 4: T340-T340. DOI: 10.1016/J.Jalz.2008.05.994 |
0.567 |
|
2007 |
Venugopal C, Pappolla MA, Sambamurti K. Insulysin cleaves the APP cytoplasmic fragment at multiple sites. Neurochemical Research. 32: 2225-34. PMID 17701350 DOI: 10.1007/S11064-007-9449-Z |
0.632 |
|
2006 |
Suram A, Venugopal C, Prakasam A, Sambamurti K. Genotoxicity in Alzheimer's disease: role of amyloid. Current Alzheimer Research. 3: 365-75. PMID 17017867 DOI: 10.2174/156720506778249380 |
0.633 |
|
2006 |
Sambamurti K, Suram A, Venugopal C, Prakasam A, Zhou Y, Lahiri DK, Greig NH. A partial failure of membrane protein turnover may cause Alzheimer's disease: a new hypothesis. Current Alzheimer Research. 3: 81-90. PMID 16472208 DOI: 10.2174/156720506775697142 |
0.664 |
|
2006 |
Sambamurti K, Prakasam A, Anitha S, Venugopal C, Cullen E, Zhou Y, Bruinsma G, Lahiri DK, Greig NH, Friedhoff L. P2-417: Oral phenserine tartrate treatment is associated with reduced plasma Abeta 1-42 in a phase I clinical study Alzheimer's & Dementia. 2: S369-S370. DOI: 10.1016/J.Jalz.2006.05.1258 |
0.537 |
|
Show low-probability matches. |